Epigral appoints Rakesh Agrawal as CFO, posts Q2 FY26 results

Management Changes View source PDF Explain this filing

EPIGRAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.3%Reaction day

₹1660.00

prior close

₹1518.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-7.9% vs market

Specialty Chemicals peers, median of 85sector-0.6%-7.7% vs sector

On the reaction day the stock moved 7.9 pts less than Nifty Microcap 250 and 7.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.7

10m

+1.4

15m

+1.0

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.3-0.4-7.9-0.6-7.7

Next day

-10.4-0.6-9.8-1.3-9.1

-7.8+0.3-8.1+0.2-8.1

-8.6+0.2-8.8-0.3-8.3

-9.5+0.1-9.6-1.4-8.1

-8.9+0.7-9.6-1.6-7.3

-11.3-0.3-11.0-3.3-8.0

15d

-10.2-2.0-8.2-5.9-4.4

-13.9-5.7-8.3-8.1-5.9

-30.6-7.8-22.8-12.3-18.3

-37.7-4.6-33.0-10.9-26.8

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Epigral's board on November 10, 2025 approved Q2 FY26 unaudited results and appointed Rakesh Agrawal as CFO. He is a Chartered Accountant with 29 plus years of experience. Q2 revenue was Rs 587.36 crore vs Rs 626.06 crore YoY. Q2 profit after tax fell to Rs 51.52 crore from Rs 80.53 crore. H1 PAT rose to Rs 211.93 crore helped by a one-time deferred tax credit of Rs 80.87 crore.

Likely market impact

Experienced CFO takes charge. Q2 profits slipped YoY but H1 looks strong on tax credit. Watch earnings momentum ahead.